BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/11/2014 3:07:00 PM | Browse: 1319 | Download: 849
 |
Received |
|
2012-12-13 14:00 |
 |
Peer-Review Started |
|
2012-12-13 17:18 |
 |
To Make the First Decision |
|
2012-12-19 11:45 |
 |
Return for Revision |
|
2013-03-19 10:14 |
 |
Revised |
|
|
 |
Second Decision |
|
2013-08-06 11:05 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2013-08-06 12:13 |
 |
Articles in Press |
|
|
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2013-09-07 21:30 |
 |
Publish the Manuscript Online |
|
2013-11-17 20:09 |
Category |
Obstetrics & Gynecology |
Manuscript Type |
Topic Highlights |
Article Title |
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in epithelial ovarian cancer: State of the art
|
Manuscript Source |
Invited Manuscript |
All Author List |
Ramez N Eskander, Luca Ansaloni, Robert E Bristow and Federico Coccolini |
Funding Agency and Grant Number |
|
Corresponding Author |
Ramez N Eskander, MD, Clinical Instructor, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Irvine Medical Center, University of California, 101 the City Drive South Orange, Irvine, CA 92868, United States. eskander@uci.edu |
Key Words |
Epithelial ovarian cancer; Cytoreductive surgery; Hyperthermic intraperitoneal chemotherapy; Intraperitoneal chemotherapy; Survival; Toxicity |
Core Tip |
Hyperthermic intraperitoneal chemotherapy (HIPEC), when used in combination with successful surgical cytoreduction appears to result in promising oncologic outcomes. We will eagerly await the results of the various phase 3 clinic trials, and until that time advocate the use of cytoreductive surgery + HIPEC in experienced centers under the auspices of appropriate institutional research programs. |
Publish Date |
2013-11-17 20:09 |
Citation |
Eskander RN, Ansaloni L, Bristow RE, Coccolini F. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in epithelial ovarian cancer: State of the art. World J Obstet Gynecol 2013; 2(4): 94-100 |
URL |
http://www.wjgnet.com/2218-6220/full/v2/i4/94.htm |
DOI |
http://dx.doi.org/10.5317/wjog.v2.i4.94 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345